Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

COCCIDIOIDES ANTIGEN #CF10023X

K-Number: K791389 · 1979-08-16

ApplicantImmuno-Mycologics, Inc.
Decision Date1979-08-16
Product CodeGMI
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

COCCIDIOIDES ANTIGEN #CF10023X is the device name listed in this FDA 510(k) record. The listed applicant is Immuno-Mycologics, Inc.. It received FDA 510(k) clearance on 1979-08-16 under 510(k) number K791389. The device is classified under product code GMI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the COCCIDIOIDES ANTIGEN #CF10023X?

COCCIDIOIDES ANTIGEN #CF10023X is a medical device that received FDA 510(k) clearance on 1979-08-16. The listed applicant is Immuno-Mycologics, Inc.. The 510(k) number is K791389.

When did COCCIDIOIDES ANTIGEN #CF10023X receive FDA 510(k) clearance?

COCCIDIOIDES ANTIGEN #CF10023X received FDA 510(k) clearance on 1979-08-16, under 510(k) number K791389.

Who is the listed applicant for COCCIDIOIDES ANTIGEN #CF10023X?

The FDA 510(k) record lists Immuno-Mycologics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for COCCIDIOIDES ANTIGEN #CF10023X?

The FDA product code for COCCIDIOIDES ANTIGEN #CF10023X is GMI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Immuno-Mycologics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K120946ALPHA CRYPTOCOCCAL ANTIGEN EIAK112422CRAG LATERAL FLOW ASSAY (LFA)K102286CRAG LATERAL FLOW ASSAY (CRAG LFA)K101407ALPHA HISTOPLASMA ANTIGEN EIA MODEL HAG102K883333RABBIT PLASMA FIBRINOGEN (RPF) SUPPLEMENTK880029EXO-ANTIGEN IDENTIFICATION SYSTEM CAT.# EX1001

View all 26 devices →

Related Devices (Code: GMI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K894617OLYMPUS PK-TP SYSTEM REACTIVE CONTROLSchiff & Co.K812190COCCIDIOIDES IMMUNODIFFUSION SYSTEMAmerican Scientific ProductsK812185FUNGAL IMMUNODIFFUSION SYSTEMAmerican Scientific ProductsK802129IMMUNODIFFUSION REAGENTS/SEROLOGICALNolan Biological Laboratories, Inc.K792716CANDIDA ALBICANS, ANTIGENMeridian Diagnostics, Inc.K792713CANDIDA ALBICANS, ANTISERUMMeridian Diagnostics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑